These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 239131)

  • 1. The animal pharmacology of drugs used in the treatment of migraine.
    Fozard JR
    J Pharm Pharmacol; 1975 May; 27(5):297-321. PubMed ID: 239131
    [No Abstract]   [Full Text] [Related]  

  • 2. [Serotonin agonists and antagonists in migraine].
    Ollat H
    Pathol Biol (Paris); 1992 Apr; 40(4):389-96. PubMed ID: 1353874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Classification, pathogenesis and drug therapy of migraine and related forms of headache].
    Fanchamps A
    Med Welt; 1975 Aug; 6(35):1518-23. PubMed ID: 241000
    [No Abstract]   [Full Text] [Related]  

  • 4. Potentiation and antagonism of serotonin effects on intracranial and extracranial vessels. Possible implications in migraine.
    Hardebo JE; Edvinsson L; Owman C; Svendgaard NA
    Neurology; 1978 Jan; 28(1):64-70. PubMed ID: 563539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serotonin and antiserotonergic agents].
    Bourin M
    Rev Prat; 1990 Jun; 40(18):1711-3. PubMed ID: 2371526
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative effects of four migraine prophylactic drugs on an isolated extracranial artery.
    Fozard JR
    Eur J Pharmacol; 1976 Mar; 36(1):127-139. PubMed ID: 1261590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Canine external carotid vasoconstriction to methysergide, ergotamine and dihydroergotamine: role of 5-HT1B/1D receptors and alpha2-adrenoceptors.
    Villalón CM; De Vries P; Rabelo G; Centurión D; Sánchez-López A; Saxena P
    Br J Pharmacol; 1999 Feb; 126(3):585-94. PubMed ID: 10188968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of some biogenic substances in migraine and relevant mechanism in antimigraine action of ergotamine--studies in an experimental model for migraine.
    Saxena PR; de Vlaam-Schluter GM
    Headache; 1974 Jan; 13(4):142-63. PubMed ID: 4149297
    [No Abstract]   [Full Text] [Related]  

  • 9. Agonists and antagonists of vascular receptors.
    Saxena PR
    Adv Neurol; 1982; 33():309-14. PubMed ID: 7034489
    [No Abstract]   [Full Text] [Related]  

  • 10. [Mechanism of action of drugs currently used in the prevention of migraine].
    Fanchamps A
    Minerva Med; 1976 Jun; 67(28):1858-60. PubMed ID: 59325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Migraine: a disease, not a symptom].
    Henry P
    Rev Prat; 2002 Jan; 52(1):5-7. PubMed ID: 11852766
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects on arterial receptors of ergot derivatives used in migraine.
    Müller-Schweinitzer E; Fanchamps A
    Adv Neurol; 1982; 33():343-56. PubMed ID: 6275676
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of antimigraine drugs on retinal spreading depression.
    Wiedemann M; de Lima VM; Hanke W
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):552-6. PubMed ID: 8740149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ergotamine and dihydroergotamine: history, pharmacology, and efficacy.
    Silberstein SD; McCrory DC
    Headache; 2003 Feb; 43(2):144-66. PubMed ID: 12558771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive agents.
    Wilhelm M; DeStevens G
    Prog Drug Res; 1976; 20():197-259. PubMed ID: 13458
    [No Abstract]   [Full Text] [Related]  

  • 16. Antagonism of beta-phenylethylamine derivatives and serotonin blocking drugs upon serotonin, tryptamine and reserpine behavioral depression in mice.
    Saavedra JM; Fischer E
    Arzneimittelforschung; 1970 Jul; 20(7):952-7. PubMed ID: 5536068
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on the 5-HT receptor in vascular smooth muscle.
    Müller-Schweinitzer E
    Res Clin Stud Headache; 1978; 6():6-12. PubMed ID: 725257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agonists and antagonists of 5-hydroxytryptamine on venomotor receptors.
    Aellig WH
    Adv Neurol; 1982; 33():321-4. PubMed ID: 7055012
    [No Abstract]   [Full Text] [Related]  

  • 19. Receptors for 5-hydroxytryptamine and noradrenaline in rabbit isolated ear artery and aorta.
    Apperley E; Humphrey PP; Levy GP
    Br J Pharmacol; 1976 Oct; 58(2):211-21. PubMed ID: 184872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of drugs applicable to treatment of migraine in the cranial circulation of the monkey.
    Lance JW; Spira PJ; Mylecharane EJ; Lord GD; Duckworth JW
    Res Clin Stud Headache; 1978; 6():13-8. PubMed ID: 103151
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.